Medical device and MedTech insights, news, tips and more

Nanox Introduces New Digital X-ray Technology That Could Significantly Reduce the Price of Medical Imaging Systems 

November 20, 2019

Nanox Arc

Nano-X Imaging Ltd. a medical imaging technology company, introduces the first commercial-grade digital X-ray technology based on a proprietary silicon MEMs semiconductor technology. This technology is introduced after 15 years of “under the radar” Japanese and Israeli development and substantial investment to overcome one of the biggest barriers to modern medical imaging. This novel digital X-ray source may enable a significant reduction in the cost of medical imaging systems, with the goal of making medical imaging more accessible and available globally.

Nanox Arc

“It is a proud moment for my team and I. We have been working for years to produce a stable digital X-ray technology that we believe can literally be the basis of saving millions of lives”, said Ran Poliakine, Founder & CEO of Nanox, “our mission is to replace all legacy sources with our digital X-ray.”

X-rays were originally discovered by Wilhelm Röntgen in 1895 and the base technology remained fundamentally unchanged for the past 124 years. In legacy systems, X- rays are generated by heating up a filament to over 2,000° Celsius which creates an electron cloud (called a “Hot Cathode”) that when pulled towards a metal anode produces X-rays on impact. This is an analog way of X-ray generation involving continuous radiation.

Led by the Israeli entrepreneur Ran Poliakine, the international teams of Israeli and Japanese engineers have achieved the digital generation of electrons without the use of heat (called a “Cold Cathode”). Nanox has built a novel “Electron Gun” based on a field emission array of a 100 million molybdenum Nano-cones (instead of the one metal filament used in legacy sources) enabling a controlled and steady generation of electrons using low voltage to achieve the same effect as the legacy X-ray source.

We believe that the Nanox digital X-ray source represents a similar analog-to-digital technology jump as the transition achieved by the lighting industry moving from a heated filament-based lightbulb designed by Edison to the modern LED.

The Company achieved operating stability of its novel X-ray source four years ago and is now moving toward commercialization of its novel X-ray source.

“There were many attempts to create a digital, Cold Cathode X-ray source over the past few decades with little to no success.” Said Hitoshi Masuya, CEO of Nanox Japan, “while some companies have made achievements using carbon nano tubes as a basis for field emission X-ray with similar approach to the one used by Nanox, to the best of our knowledge no company have achieved a commercially stable source that can be embedded inside a medical imaging system and operate with an acceptable lifespan. We are proud at our achievement and look forward to beginning to revolutionizing medical imaging in the world.”

See Full Press Release: Nanox Introduces Digital X-ray Technology | Business Wire


Written by: Nanox


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.